| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 35.06B | 40.16B | 32.61B | 25.34B | 29.09B | 28.17B |
| Gross Profit | 14.43B | 16.04B | 13.10B | 8.94B | 11.52B | 10.55B |
| EBITDA | 10.92B | 11.98B | 9.73B | 6.44B | 8.78B | 8.07B |
| Net Income | 5.61B | 6.11B | 5.28B | 3.08B | 5.00B | 3.80B |
Balance Sheet | ||||||
| Total Assets | 80.98B | 88.20B | 78.86B | 70.61B | 69.14B | 64.53B |
| Cash, Cash Equivalents and Short-Term Investments | 18.50B | 18.11B | 18.13B | 20.07B | 20.97B | 17.58B |
| Total Debt | 435.00M | 0.00 | 427.00M | 186.00M | 890.00M | 313.00M |
| Total Liabilities | 6.87B | 8.20B | 5.72B | 3.32B | 5.51B | 5.47B |
| Stockholders Equity | 74.11B | 80.00B | 73.14B | 67.28B | 63.63B | 59.06B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 76.00M | 3.18B | 228.00M | 4.18B | 3.21B |
| Operating Cash Flow | 0.00 | 7.51B | 7.28B | 4.69B | 6.71B | 5.83B |
| Investing Cash Flow | 0.00 | -6.80B | -7.27B | -5.01B | -1.96B | -3.16B |
| Financing Cash Flow | 0.00 | -2.26B | -1.68B | -1.61B | -1.55B | -1.44B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥163.56B | 7.03 | ― | 2.33% | 25.95% | 66.92% | |
77 Outperform | ¥21.71B | 14.20 | ― | 3.31% | 0.97% | -10.47% | |
72 Outperform | ¥259.14B | 24.11 | ― | 1.17% | 29.51% | 48.81% | |
72 Outperform | ¥235.15B | 13.29 | 7.86% | 2.55% | 0.57% | 4.54% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥112.98B | 17.03 | 2.64% | 2.30% | -4.11% | 46.76% | |
50 Neutral | ¥12.50B | -0.51 | ― | 6.98% | -11.46% | 43.93% |